Experience with a single-pass, dual-electrode implantable atrial defibrillator lead for maintaining sinus rhythm in patients with recurrent atrial fibrillation.
The implantable atrial defibrillator is a new potential nonpharmacologic treatment for recurrent atrial fibrillation. The results of this study suggest that a simplified lead configuration, with a single-pass, dual-electrode atrial defibrillation lead can be used for both atrial fibrillation detection and defibrillation with an implantable atrial defibrillator.